Supplier Type
- Manufacturer
- contract manufacturer
- Trader
- custom synthesis
- Reagent
Supplier Region
- Hyderabad(21)
- Ahmedabad(17)
- Tamil Nadu(3)
- Gujarat(31)
- New Delhi(7)
- Maharashtra(39)
- Beijing(3)
- Karnataka(7)
- Andhra Pradesh(4)
- Mumbai(64)
- Vadodara(14)
- Delhi(14)
- Pune(5)
- Telangana(1)
- Madhya Pradesh(2)
- Uttar Pradesh(10)
- Haryana(4)
- Kerela(1)
- Himachal Pradesh(1)
- Punjab(2)
- Bangalore(2)
- Kolkata(2)
- Nagpur(1)
- Rajasthan(1)
Purity
- Standard Crude
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT95%
- NLT 95%
- NLT 90%
- NA
- more than 95%
- more than 90%
- Min. 36 %
- Min 98%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Content of Chromium Min. 25%
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.9 %
- 99.86%
- 99.85%
- 99.73%
- 99.42%
- 99.29%
- 99%+
- 99%,HPLC
- 99% min.
- >99%
- 99%
- 99 %
- 99
- 98+
- 98.60%
- >98.5%
- 98.12%
- 98% Min
- 98% (HPLC)
- 98%
- >98%
- 98
- 97-99%
- 97-99 %
- 97.57%
- 97%
- >97%
- 97 %
- 96-98%
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95-99%
- 95.48%
- >95%
- 95%
- >92%
- >90%
- 90%
- 85%
- 80%
- 50%
- 36%
- 30%,60%&90%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100% Pure
- 100%
- <1.00% max
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25MG
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 36kg
- 50kg
- 100kg
- 174kg
- 500kg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 250kg
- 1MT
- 1drum
- 5gms
- 25gms
- 95NLT %
- 200Kg drum
-
Valsartan Impurity 32
152708-24-2
-
N-[2’-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine benzyl ester
137863-20-8
-
Vildagliptin Related Compound F
1789703-36-1
-
Chlorthalidone Impurity D
1369995-36-7
-
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
1159977-36-2
-
Salmeterol-N-Alkyl Impurity (Usp)
2470130-36-8
-
2-Amino-2',5-dichlorobenzophenone
2958-36-3
-
1,1[(1-Methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]-2-propanol_x000b_(Mixture of diastereomers)
154784-36-8
-
Losartan Carboxaldehyde
114798-36-6
-
2H-2-Ethyl Candesartan Cilexetil
914613-36-8
Valsartan Impurity 13 152708-24-2
Ethyl bromoacetate 105-36-2
Chlorthalidone 77-36-1
Direct orange 26 3626-36-6
6-Chlorohexanal 52387-36-7
Direct orange 26 3626-36-6
1-Butanol 71-36-3
Antimony 7440-36-0
Direct orange 26 3626-36-6
Valsartan 137862-53-4


